The Ride to Conquer Cancer Presented by Wheaton Precious Metals™ benefiting the BC Cancer Foundation is a unique, two-day cycling event to take place on August 29 and 30, 2020, journeying over 200km through BC. The Ride is a bold endeavor to Conquer Cancer. The money raised for The Ride to Conquer Cancer will benefit the BC Cancer Foundation, supporting breakthrough research and enhancements to care at BC Cancer.
THE RIDE TO CONQUER CANCER® PRESENTED BY WHEATON PRECIOUS METALS™ BENEFITING BC CANCER FOUNDATION ANNOUNCES $9.1 MILLION RAISED IN ANNUAL EVENT, COLLECTIVELY RAISING OVER $105.1 MILLION IN 11 YEARS
British Columbia’s largest cycling fundraiser draws 2,100 Riders in 11th annual event, cycling over 200 kilometres in two days to support breakthrough research and care at BC Cancer
FOR IMMEDIATE RELEASE
SURREY, B.C., August 24, 2019 – The Ride to Conquer Cancer® Presented by Wheaton Precious Metals™ benefiting the BC Cancer Foundation announced 2,100 Riders helped raise $9.1 million for the BC Cancer Foundation as the 11th annual Ride commenced in Surrey at the Cloverdale Rodeo & Exhibition Grounds this morning.
In 11 years, the B.C. Ride has raised over $105.1 million to support more than 47 world-leading research projects underway at BC Cancer, advancing care and providing hope to over 77,000 people facing cancer across British Columbia. The B.C. Ride is the province’s largest fundraising event.
“In 11 epic years, the Ride to Conquer Cancer has played an essential role in breaking down cancer and saving lives in our province. With thousands of cyclists and tens of thousands of donors, the Ride brings us the hope that together, we are closer to conquering cancer,” says Sarah Roth, president and CEO, BC Cancer Foundation.
“We Ride and raise funds to honour those currently facing the disease, for those we’ve lost and to fuel the work of the incredible scientists and clinicians at BC Cancer. From the bottom of our hearts, we thank all riders, donors, volunteers, crew, sponsors and supporters for your commitment as we cycle together to change outcomes,” adds Roth.
The annual event draws thousands of participants and brings together communities of cancer survivors, cyclists and supporters who train and fundraise for months to participate. The two-day, 200-kilometre Ride will journey through the Fraser Valley from Surrey to Hope, with an overnight in Chilliwack.
“Every year I ride for cancer I am reminded of all that BC Cancer and its staff has done for me and how lucky I am to be alive. I have what I refer to as a dream team of doctors working to make my life as healthy and productive as possible,” said Rick Davis, cancer survivor from White Rock, British Columbia. “If it weren’t for all of the support I received from BC Cancer and its staff, I wouldn’t be here today sharing my story,” adds Davis.
Wheaton Precious Metals™ became the presenting sponsor of the Ride to Conquer Cancer in 2014. Their team, The Silver Bullets, has raised more than $1.5 million in ten years. Sponsorship funds donated by Wheaton Precious Metals™ enable Ride participants to directly support the world-leading work of experts at BC Cancer.
“As presenting sponsor, Wheaton Precious Metals™ is honoured to be a part of the Ride and its many years of success and outstanding impact,” says Randy Smallwood, President and CEO of Wheaton Precious Metals™ and captain of The Silver Bullets.
“We’d like to congratulate and thank all Riders who are changing outcomes for patients and their families each time they hit the pavement and pedal every kilometre with pride. Wheaton Precious Metals™ is committed to supporting the breakthrough research and life-saving care at BC Cancer, and we look forward to riding with you all again in 2020,” Smallwood added.
Next year’s dates have been released: the 12th annual Ride to Conquer Cancer Presented by Wheaton Precious Metals™ will be held on August 29 and 30th, 2020. For more details visit www.conquercancer.ca or call (888) 771-2453.
The BC Cancer Foundation is the fundraising partner of BC Cancer. Together with our donors we are changing the outcome for people affected by cancer in B.C. and beyond by connecting personalized care, innovative research and opportunities to contribute. We are the largest funder of cancer in B.C. and every dollar raised stays right here at BC Cancer to advance research, enhance care and break down cancer to benefit the people of B.C.
PR & Communications Manager
(905) 334 6170
BC Cancer Foundation
RIDE TO CONQUER CANCER PARTNERS WITH LOUIS GARNEAU AS THE OFFICIAL CYCLING APPAREL SPONSOR
December 12, 2019
A leader in the cycling community joins forces with Canada’s largest peer-to-peer fundraising event
FOR IMMEDIATE RELEASE:
VANCOUVER, DECEMBER 12, 2018 – The Ride to Conquer Cancer announces Garneau as the Official Cycling Apparel Sponsor for the Canadian national event series. Thousands of participants in British Columbia, Alberta, Ontario and Quebec will take on the bold challenge of cycling over 200-kilometres in two days for cancer research and treatment. They will be united in Louis Garneau top-quality jerseys to empower them during their cycling challenge.
For 35 years, Garneau has been involved in initiatives that give back to the cycling community and bring people together. The leading manufacturer will continue their mission by partnering with the Ride to Conquer Cancer this year.
“We are proud to support events that rally so many cyclists across Canada pedaling in the fight to end cancer. Never Give Up is our motto at Garneau and we will embody this message every step of the way in this partnership,” says Michael Britten, Sales Director, Garneau.”
“The Ride is made up of a large and passionate community of cyclists that comes together every year to advance cancer research,” says Lindsay Carswell, Director of the Ride to Conquer Cancer at the BC Cancer Foundation. “It is delightful to be partnering with Garneau, a company that has a similar commitment to innovation and fuelled by a deep-rooted desire to bring people together.”
Since 2008, the event has raised more than $421 million nationwide.
About The Ride to Conquer CancerTM
The Ride to Conquer Cancer is a unique, two-day cycling event, journeying over 200-kilometres through British Columbia, Alberta, Ontario and Quebec. The Ride is a bold endeavour to conquer cancer in our lifetime. The money raised for The Ride benefits world-class institutions across the country, supporting healthcare professionals whose search for new discoveries and improved patient outcomes will have a real impact in communities, across Canada and around the world. Since 2008, the Ride to Conquer Cancer event series has raised nearly $421 million for partners in Canada.
Garneau was founded in 1983, and like so many others successful companies such as Apple, Microsoft, HP, Google, Amazon, not to mention innumerable rock bands, the company had its first headquarters in Louis’ father’s garage. Today, Garneau is an industry leader in cycling and triathlon apparel, helmets, shoes, bikes as well as nordic apparel, accessories, snowshoes and nutrition. The products we design represent our technological expertise and innovative engineering well and push back the limits of what is established in sports.
Garneau sets benchmarks for technology and performance in the industry and transforms intuitive ideas into intelligent products. Our products are tested and used by some of the best athletes in the world including Lionel Sanders, Team Rwanda, and Cycling Canada. We have indeed come a long way since Louis’ debut in the family’s garage!
ABOUT THE RIDE
The Ride to Conquer Cancer® presented by Wheaton Precious Metals® is a unique, two-day cycling event to take place on August 29 and 30, 2020, journeying over 200km throughout British Columbia. Our mission is clear – a world free from cancer. The money raised for The Ride to Conquer Cancer will benefit the BC Cancer Foundation, supporting breakthrough research and enhancements to care at BC Cancer. Funds raised ensure researchers and clinicians at BC Cancer have the support needed to re- invent the standard of cancer care through leading-edge research.